Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ATRA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Nguyen AnhCo Director, Officer | ATRA Atara Biotherapeutics, Inc. | 5,062 | $42.3K | — | Aug 17, 2026 | — | Form 144 ↗ |
| May 18, 2026 | Nguyen AnhCo Director, Officer | ATRA Atara Biotherapeutics, Inc. | 5,981 | $62.7K | — | May 18, 2026 | Form 4 ↗ 2 days later · 5,241 shares | Form 144 ↗ |
| May 18, 2026 | Grant-Huerta Yanina Officer | ATRA Atara Biotherapeutics, Inc. | 2,754 | $28.9K | — | May 18, 2026 | Form 4 ↗ 2 days later · 2,414 shares | Form 144 ↗ |
| May 7, 2026 | Panacea Innovation Ltd 10% Stockholder | ATRA Atara Biotherapeutics, Inc. | 313,446 | $3.2M | — | May 7, 2026 | Form 4 ↗ 4 days later · 313,446 shares | Form 144 ↗ |
| Mar 2, 2026 | Nguyen AnhCo Director, Officer | ATRA Atara Biotherapeutics, Inc. | 3,355 | $18.2K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 2,996 shares | Form 144 ↗ |
| Mar 2, 2026 | Grant-Huerta Yanina Officer | ATRA Atara Biotherapeutics, Inc. | 2,355 | $12.8K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 2,104 shares | Form 144 ↗ |
| Jan 12, 2026 | Panacea Innovation Ltd 10% Stockholder | ATRA Atara Biotherapeutics, Inc. | 20,554 | $120.9K | — | Jan 12, 2026 | Form 4 ↗ 2 days later · 80,554 shares | Form 144 ↗ |
| Jan 12, 2026 | Panacea Innovation Ltd 10% Stockholder | ATRA Atara Biotherapeutics, Inc. | 20,000 | $117.6K | — | Jan 12, 2026 | Form 4 ↗ 2 days later · 80,554 shares | Form 144 ↗ |
| Jan 12, 2026 | Panacea Innovation Ltd 10% Stockholder | ATRA Atara Biotherapeutics, Inc. | 40,000 | $235.2K | — | Jan 12, 2026 | Form 4 ↗ 2 days later · 80,554 shares | Form 144 ↗ |
| Nov 17, 2025 | Nguyen AnhCo Director, Officer | ATRA Atara Biotherapeutics, Inc. | 3,346 | $46.0K | — | Nov 17, 2025 | Form 4 ↗ 2 days later · 2,915 shares | Form 144 ↗ |
| Nov 17, 2025 | Grant-Huerta Yanina Officer | ATRA Atara Biotherapeutics, Inc. | 2,069 | $28.5K | — | Nov 17, 2025 | Form 4 ↗ 2 days later · 1,804 shares | Form 144 ↗ |
| Aug 18, 2025 | Nguyen AnhCo Director, Officer | ATRA Atara Biotherapeutics, Inc. | 3,346 | $41.1K | — | Aug 18, 2025 | Form 4 ↗ 2 days later · 2,958 shares | Form 144 ↗ |
| Aug 18, 2025 | Grant-Huerta Yanina Officer | ATRA Atara Biotherapeutics, Inc. | 2,048 | $25.2K | — | Aug 18, 2025 | Form 4 ↗ 2 days later · 1,809 shares | Form 144 ↗ |
| May 16, 2025 | Nguyen AnhCo Director, Officer | ATRA Atara Biotherapeutics, Inc. | 3,471 | $26.4K | — | May 16, 2025 | Form 4 ↗ 4 days later · 3,276 shares | Form 144 ↗ |
| May 16, 2025 | Grant-Huerta Yanina Officer | ATRA Atara Biotherapeutics, Inc. | 2,350 | $17.9K | — | May 16, 2025 | Form 4 ↗ 4 days later · 2,218 shares | Form 144 ↗ |
| Mar 3, 2025 | Nguyen AnhCo Officer, Director | ATRA Atara Biotherapeutics, Inc. | 3,929 | $27.1K | — | Mar 3, 2025 | Form 4 ↗ 2 days later · 3,331 shares | Form 144 ↗ |
| Mar 3, 2025 | Eric J. Hyllengren Officer | ATRA Atara Biotherapeutics, Inc. | 1,426 | $9,854 | — | Mar 3, 2025 | Form 4 ↗ 2 days later · 1,211 shares | Form 144 ↗ |
| Mar 3, 2025 | Jill Henrich Officer | ATRA Atara Biotherapeutics, Inc. | 1,245 | $8,603 | — | Mar 3, 2025 | Form 4 ↗ 2 days later · 1,059 shares | Form 144 ↗ |
| Nov 18, 2024 | Nguyen AnhCo Officer, Director | ATRA Atara Biotherapeutics, Inc. | 1,857 | $22.3K | — | Nov 18, 2024 | Form 4 ↗ 2 days later · 1,664 shares | Form 144 ↗ |
| Nov 18, 2024 | Murugan Amar Former Officer | ATRA Atara Biotherapeutics, Inc. | 1,342 | $16.1K | — | Nov 18, 2024 | — | Form 144 ↗ |
| Nov 18, 2024 | Eric J. Hyllengren Officer | ATRA Atara Biotherapeutics, Inc. | 1,517 | $18.2K | — | Nov 18, 2024 | Form 4 ↗ 2 days later · 1,364 shares | Form 144 ↗ |
| Nov 18, 2024 | Jill Henrich Officer | ATRA Atara Biotherapeutics, Inc. | 1,112 | $13.3K | — | Nov 18, 2024 | Form 4 ↗ 2 days later · 1,000 shares | Form 144 ↗ |
| Aug 16, 2024 | Touchon Pascal Director, Officer | ATRA Atara Biotherapeutics, Inc. | 3,525 | $28.3K | — | Aug 16, 2024 | — | Form 144 ↗ |
| Aug 16, 2024 | Nguyen AnhCo Officer | ATRA Atara Biotherapeutics, Inc. | 2,114 | $17.0K | — | Aug 16, 2024 | — | Form 144 ↗ |
| Aug 16, 2024 | Murugan Amar Officer | ATRA Atara Biotherapeutics, Inc. | 1,342 | $10.8K | — | Aug 16, 2024 | — | Form 144 ↗ |
| Aug 16, 2024 | Eric J. Hyllengren Officer | ATRA Atara Biotherapeutics, Inc. | 1,239 | $9,937 | — | Aug 16, 2024 | — | Form 144 ↗ |
| Aug 16, 2024 | Jill Henrich Officer | ATRA Atara Biotherapeutics, Inc. | 1,113 | $8,926 | — | Aug 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Touchon Pascal Director, Officer | ATRA Atara Biotherapeutics, Inc. | 88,061 | $56.4K | — | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Nguyen AnhCo Officer | ATRA Atara Biotherapeutics, Inc. | 28,251 | $18.1K | — | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Murugan Amar Officer | ATRA Atara Biotherapeutics, Inc. | 34,946 | $22.4K | — | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Eric J. Hyllengren Officer | ATRA Atara Biotherapeutics, Inc. | 30,907 | $19.8K | — | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Jill Henrich Officer | ATRA Atara Biotherapeutics, Inc. | 27,754 | $17.8K | — | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Nguyen AnhCo Officer | ATRA Atara Biotherapeutics, Inc. | 10,728 | $8,268 | — | Mar 4, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Touchon Pascal Director, Officer | ATRA Atara Biotherapeutics, Inc. | 24,816 | $19.1K | — | Mar 4, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Jill Henrich Officer | ATRA Atara Biotherapeutics, Inc. | 3,865 | $2,979 | — | Mar 4, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Eric J. Hyllengren Officer | ATRA Atara Biotherapeutics, Inc. | 6,655 | $5,129 | — | Mar 4, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Murugan Amar Officer | ATRA Atara Biotherapeutics, Inc. | 10,024 | $7,726 | — | Mar 4, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Nguyen Tran Officer | ATRA Atara Biotherapeutics, Inc. | 10,728 | $8,268 | — | Mar 4, 2024 | — | Form 144 ↗ |
38 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 9:26 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances